Neurotez

Early Stage

Neurotez Inc. is developing a drug to treat Leptin deficiency in Alzheimer’s patients.

Analytics

Raised to Date: Raised: $29,444

Aggregate Commitments $

Platform

StartEngine

Start Date

11/09/2021

Close Date

02/08/2022

Min. Goal

$10,000

Max. Goal

$281,096

Min. Investment

$496

Security Type

Equity - Common

Funding Type

RegCF

Series

Pre-Seed

Pre-Money Valuation

$44,870,036

Rolling Commitments $

Status

Active

Reporting Date

12/05/2021

Days Remaining

65

% of Min. Goal

294%

% of Max. Goal

10%

Likelihood of Max
unlikely
Avg. Daily Raise

$1,132

Momentum
warm.svg
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Bridgewater, New Jersey

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B2C

Margin

Low

Capital Intensity

High

Business Type

Growth

Neurotez, with a valuation of $44.9 million, is raising funds on StartEngine. The company is developing a hormone replacement therapy named Memtin to treat Leptin deficiency in Alzheimer’s patients. The drug will help slow down the cognitive decline in Alzheimer’s patients and other forms of dementia. Neurotez has already received many rewards and recognitions and is backed by an excellent team of experts. Nikolaos Tezapsidis founded Neurotez in 2005. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $281,096. The campaign proceeds will be used for the execution and delivery of data from its Phase 1B trial.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$9,115

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-188,407

$-367,295

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$5,882

$283

Accounts Receivable

$0

$0

Total Assets

$164,744

$176,536

Short-Term Debt

$420,466

$396,332

Long-Term Debt

$0

$26,000

Total Liabilities

$420,466

$422,332

Financials as of: 11/09/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Neurotez 02/08/2022 StartEngine $44,870,036 $29,444 Equity - Common Active RegCF
Neurotez 06/24/2021 Netcapital $21,959,058 $255,718 Equity - Common Funded RegCF
Neurotez 02/26/2018 Netcapital $24,544,690 $95,809 Equity - Common Funded RegCF
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Neurotez on StartEngine 2021
$
Platform: StartEngine
Security Type: Equity - Common
Valuation: $44,870,036
Invest in a different round for this company? Use my investment date to determine which raise I invested in.

Follow company

Follow Neurotez on StartEngine 2021